HKU Scholars Hub: Browsing DSpace

Browsing by Author Miranda, RN

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 6 of 6

	Title	Author(s)	Issue Date	Views
	CD30 expression defines a novel subset of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from The International DLBCL Rituximab-CHOP Consortium Program Study Journal:Blood	Hu, S Xu-Monette, ZY Balasubramanyam, A Manyam, GC Visco, C Tzankov, A Liu, WM Miranda, RN Zhang, L Montes-Moreno, S Dybkaer, K Chiu, A Orazi, A Zu, Y Bhagat, G Richards, KL Hsi, ED Choi, WL van Krieken, JH Huang, Q Huh, J Ai, W Ponzoni, M Ferreri, AJ Zhao, X Winter, JN Zhang, M Li, L Moller, MB Piris, MA Li, Y Go, RS Wu, L Medeiros, LJ Young, KH	2013	89
	Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study Journal:Leukemia	Visco, C Li, Y Xu-Monette, ZY Miranda, RN Green, TM Li, Y Tzankov, A Wen, W Liu, WM Kahl, BS d'Amore, ESG Montes-Moreno, S Dybkaer, K Chiu, A Tam, W Orazi, A Zu, Y Bhagat, G Winter, JN Wang, HY O'Neill, S Dunphy, CH Hsi, ED Zhao, XF Go, RS Choi, WWL Zhou, F Czader, M Tong, J Zhao, X van Krieken, JH Huang, Q Ai, W Etzell, J Ponzoni, M Ferreri, AJM Piris, MA Moller, MB Bueso-Ramos, CE Medeiros, LJ Wu, L Young, KH	2012	185
	Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study Journal:Blood	Xu-Monette, ZY Wu, L Visco, C Tai, YC Tzankov, A Liu, WM Montes-Moreno, S Dybkaer, K Chiu, A Orazi, A Zu, Y Bhagat, G Richards, KL Hsi, ED Zhao, XF Choi, WL Zhao, X van Krieken, JH Huang, Q Huh, J Ai, W Ponzoni, M Ferreri, AJ Zhou, F Kahl, BS Winter, JN Xu, W Li, J Go, RS Li, Y Piris, MA Moller, MB Miranda, RN Abruzzo, LV Medeiros, LJ Young, KH	2012	121
	MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program Journal:Blood	Hu, S Xu-Monette, ZY Tzankov, A Green, T Wu, L Balasubramanyam, A Liu, WM Visco, C Li, Y Miranda, RN Montes-Moreno, S Dybkaer, K Chiu, A Orazi, A Zu, Y Bhagat, G Richards, KL Hsi, ED Choi, WWL Zhao, X van Krieken, JH Huang, Q Huh, J Ai, W Ponzoni, M Ferreri, AJM Zhou, F Slack, GW Gascoyne, RD Tu, M Variakojis, D Chen, W Go, RS Piris, MA Møller, MB Medeiros, LJ Young, KH	2013	46
	Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study Journal:Haematologica	Visco, C Tzankov, A Xu-Monette, ZY Miranda, RN Tai, YC Li, Y Liu, WM d'Amore, ES Montes-Moreno, S Dybkaer, K Chiu, A Orazi, A Zu, Y Bhagat, G Wang, HY Dunphy, CH Hsi, ED Zhao, XF Choi, WL Zhao, X van Krieken, JH Huang, Q Ai, W O'Neill, S Ponzoni, M Ferreri, AJ Kahl, BS Winter, JN Go, RS Dirnhofer, S Piris, MA Moller, MB Wu, L Medeiros, LJ Young, KH	2013	92
	The t(14;18)(q32;q21) characterizes a subset of patients with diffuse large-B cell lymphoma of germinal center origin with poor outcome: report from the International DLBCL Rituximab-CHOP Consortium Program Study Proceeding/Conference:Blood	Visco, C Tzankov, A Xu-Monette, ZY Miranda, RN d'Amore, ESG Montes-Moreno, S Dybkae, K Chiu, A Tam, W Orazi, A Zu, Y Bhagat, G Kahl, BS Winter, JN Wang, HY Dunphy, CH Hsi, ED Zhao, FX Go, RS Choi, WWL Zhou, F Czader, M Zhao, X Van Krieken, JHJM Huang, Q Ai, W Etzell, JE Ponzoni, M Ferreri, AJM Piris, MA Møller, MB Bueso-Ramos, CE Medeiros, LJ Young, KH	2011	177

Showing results 1 to 6 of 6